中国现代普通外科进展
中國現代普通外科進展
중국현대보통외과진전
CHINESE JOURNAL OF CURRENT ADVANCES IN GENERAL SURGERY
2002年
1期
40-41
,共2页
韦长元%杨伟萍%刘剑仑%杨南武%陈建思%刘悠南
韋長元%楊偉萍%劉劍崙%楊南武%陳建思%劉悠南
위장원%양위평%류검륜%양남무%진건사%류유남
32磷玻璃微球%肝肿瘤%栓塞
32燐玻璃微毬%肝腫瘤%栓塞
32린파리미구%간종류%전새
Phosphate-32 glass microspheres%Liver neoplasms%Embolism
目的:探讨32磷玻璃微球内放射栓塞治疗中晚期肝癌的效果.方法:应用32磷玻璃微球通过介入方法治疗肝癌21例.结果:治疗后用彩色多谱勒超声和SPECT肝扫描显示肝动脉灌注32磷玻璃微球后肿瘤动脉血供明显减少或消失,肿瘤体积缩小,32磷玻璃微球聚集于肿瘤区内,治疗后6、12、18个月生存率分别为85.7%、61.9%、57.1%,无明显毒副反应.结论:32磷玻璃微球内放射栓塞治疗中晚期肝癌是一种有效的治疗手段.
目的:探討32燐玻璃微毬內放射栓塞治療中晚期肝癌的效果.方法:應用32燐玻璃微毬通過介入方法治療肝癌21例.結果:治療後用綵色多譜勒超聲和SPECT肝掃描顯示肝動脈灌註32燐玻璃微毬後腫瘤動脈血供明顯減少或消失,腫瘤體積縮小,32燐玻璃微毬聚集于腫瘤區內,治療後6、12、18箇月生存率分彆為85.7%、61.9%、57.1%,無明顯毒副反應.結論:32燐玻璃微毬內放射栓塞治療中晚期肝癌是一種有效的治療手段.
목적:탐토32린파리미구내방사전새치료중만기간암적효과.방법:응용32린파리미구통과개입방법치료간암21례.결과:치료후용채색다보륵초성화SPECT간소묘현시간동맥관주32린파리미구후종류동맥혈공명현감소혹소실,종류체적축소,32린파리미구취집우종류구내,치료후6、12、18개월생존솔분별위85.7%、61.9%、57.1%,무명현독부반응.결론:32린파리미구내방사전새치료중만기간암시일충유효적치료수단.
To determine the therapeutic effects of hepatic radioembolization with phosphorus32 glass microsphere(32P-GMS)in the treatment of hepatocellular carcinoma(HCC).Methods:21 cases of HCC had received the hepatic radioembolization by 32P-GMS.Results:The blood flow in the hepatic artery of tumor area reduced remarkagbly, even nearlydisappeared,the size of tumor was smaller after the hepatic artery administration with 32P-GMS.The survival rate of 6,12,and 18 months was 85.7%,61.9%,57.1%respectively.Conclusion:The lntraradioembolization is effective therapy for the advanced HCC.
